Infectious Disease

Top Story

Cidara receives orphan drug status for antifungal to treat Candida infections

Cidara receives orphan drug status for antifungal to treat <em> Candida </em> infections
February 11, 2016

Cidara Therapeutics has received an orphan drug designation from the FDA for its antifungal drug candidate to treat life-threatening Candida infections, the company announced.

The novel echinocandin drug, CD101 IV, treats candidemia and invasive candidiasis, serious fungal infections associated with high mortality rates and rising drug resistance.

WHO releases Zika guidance for pregnant women

February 11, 2016
WHO officials recently released guidance on Zika virus infection for women who are pregnant or are planning to become pregnant. On Feb. 1, WHO Director-General Margaret

GI outbreak sickens 186 students at Pennsylvania college

February 11, 2016
An unidentified gastrointestinal illness has sickened at least 186 students at Ursinus College in Pennsylvania, as well as some members of the faculty and staff…
In the Journals

Novel microbiome therapy appears to prevent recurrent C. difficile infection

February 11, 2016
An investigational oral microbiome-based therapeutic safely and effectively prevented recurrent Clostridium difficile infection in patients with multiple recurrent…

Guest commentary: Emerging resistance, continuous progress in antifungal drug development

February 11, 2016
In this guest commentary, Dimitrios Kontoyiannis, MD, the Frances King Black Endowed Professor in the department of infectious diseases, The University of Texas MD
More News Headlines »

The Adolescent Patient with Meningococcal Meningitis

No commercial support for this activity.

Although not common, meningococcal meningitis is a serious condition, and can result in extensive morbidity and…
More »

VIDEO: Origins of cardiovascular events in HIV involve ‘a number of different angles’

December 11, 2015
More »

Evolution of HIV Treatment: How to Start, How to Switch, How to Treat HIV/HCV Co-infection

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Improvements in antiretroviral therapy (ART) continue to be made with the development of simplified, single-tablet…
More »
morganatic-roan morganatic-roan